Establishing the Intrinsic Regenerative Capacity of the Adult Human Heart in Health and Disease and the use of Recombinant Cellular Growth Factors to Reverse Heart Failure in vitro
Establishing the Intrinsic Regenerative Capacity of the Adult Human Heart in Health and Disease and the use of Recombinant Cellular Growth Factors to Reverse Heart Failure in vitro
批准号:
nhmrc : 1093852
负责人:
Dr Sean Lal
金额:
$7.38万
依托单位国家:
澳大利亚
项目类别:
Postgraduate Scholarships
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31
中文摘要
心力衰竭是澳大利亚发病率和死亡率的主要原因。我们希望通过证明人类心脏可以再生来改变这种黯淡的前景,从而挑战长期以来认为我们的心脏不能再生的教条。使用人类心脏样本,我们将测量这些细胞在心力衰竭中再生的内在能力,并将其与正常、健康衰老的情况进行比较。此外,我们将探索使用细胞外生长因子来刺激这些心肌细胞
英文摘要
Heart failure is a major cause of morbidity and mortality in Australia. We hope to change this bleak outlook by showing that the human heart can regenerate, thereby challenging the long-held dogma that our heart cannot regrow. Using human heart samples we will measure the intrinsic capability of these cells to regenerate in heart failure compared to what occurs in normal, healthy ageing. In addition, we will explore the use of extracellular growth factors to stimulate these heart muscle cells
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位: